Table 1.
Baseline clinical characteristics of SLE patients
| Characteristic | SLE (n = 80) |
|---|---|
| Duration of disease, months, median (IQR) | 36 (12–72) |
| BMI kg/m2 (Mean ± SD) | 23.19 ± 5.33 |
| SBP, mean ± SD | 119.8 ± 22.94 |
| DBP, mean ± SD | 77.05 ± 11.04 |
| Malar rash | 52 (65) |
| Discoid rash | 21 (26.25) |
| Photosensitivity | 58 (72.5) |
| Alopecia | 61 (76.25) |
| Oral ulcers | 56 (70) |
| Serositis | 14 (17.5) |
| Arthralgia or arthritis | 69 (86.25) |
| Lupus Nephritis | 36 (45) |
| Neuropsychiatric manifestations | 31 (38.8) |
| Left ventricular ejection fraction < 50% (data for 78) | 5 (6.4) |
| Vasculitis | 8 (10) |
| Gastrointestinal involvement | 3 (3.75) |
| Leukopenia (Total Leukocyte Count < 4000/mm3) | 23 (28.8) |
| Thrombocytopenia (platelet count < 1,00,000/mm3) | 18 (22.5) |
| Autoimmune haemolytic anemia | 12 (15) |
| Antiphospholipid syndrome | 4 (5) |
| SLEDAI mean (SD) | 9.66 ± 6.85 |
| SLICC/ACR Damage Index, median (IQR) | 0 (0-1) |
| Hypertension | 16 (20) |
| Diabetes mellitus | 11 (13.75) |
| Hypothyroidism | 19 (46.34) |
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, SLEDAI systemic lupus erythematosus disease activity index; Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index